Oxygen Therapy Market Size, Growth Strategies, Trends, Analysis and Forecast 2024-2032

According to IMARC Group latest report titled “Oxygen Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on oxygen therapy market growth. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global oxygen therapy market size reached US$ 18.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032.

Request a Sample Report: https://www.imarcgroup.com/oxygen-therapy-market/requestsample

Oxygen Therapy Market Overview:

Oxygen therapy is a medical treatment that involves administering oxygen at higher concentrations than what is found in the air we breathe. It's commonly used to treat conditions where the body's oxygen levels are low, such as chronic obstructive pulmonary disease (COPD), pneumonia, and severe asthma. This therapy is delivered through various devices, including nasal prongs, masks, and ventilators, depending on the severity of the condition and the patient's needs. The goal of oxygen therapy is to increase the amount of oxygen in the blood, which helps improve breathing and alleviate symptoms such as shortness of breath, fatigue, and confusion. It can also enhance the body's ability to function properly, especially during physical activity or times of stress. Oxygen therapy is prescribed by healthcare professionals based on individual patient assessments, and it's typically used as a long-term treatment for chronic conditions or as a short-term intervention during acute illness or injury.

Oxygen Therapy Market Trends:

The increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia is driving the global market. The growing awareness among healthcare providers and patients regarding the benefits of oxygen therapy also plays a crucial role. With advancements in medical research and technology, the effectiveness of oxygen therapy in managing various respiratory conditions is becoming increasingly evident. This awareness leads to higher adoption rates of oxygen therapy devices and services. Moreover, the expanding geriatric population contributes significantly to the growth of the market across the globe.

Furthermore, technological advancements and innovations in oxygen delivery systems are augmenting the market growth. Manufacturers are continuously developing advanced oxygen therapy devices that are more efficient, portable, and user-friendly. Additionally, the COVID-19 pandemic has further propelled the demand for oxygen therapy products. The rise in COVID-19 cases worldwide has led to a heightened demand for oxygen therapy devices, including oxygen concentrators, ventilators, and oxygen cylinders.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/oxygen-therapy-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Allied Healthcare Products Inc.
• Becton Dickinson and Company
• DeVilbiss Healthcare LLC (Drive Medical Inc.)
• Fisher & Paykel Healthcare Limited
• General Electric Company
• Getinge AB
• Hersill SL
• Invacare Corporation
• Koninklijke Philips N.V
• Smiths Group plc
• Tecno-Gaz S.p.A.
• Teleflex Incorporated.

Oxygen Therapy Market Segmentation:

Our report has categorized the market based on region, product, application and end use.

Breakup by Product:

• Oxygen Source Equipment

  • Oxygen Cylinders
  • Oxygen Concentrators
  • Liquid Oxygen Devices
  • PAP Devices

• Oxygen Delivery Devices

  • Oxygen Masks
  • Nasal Cannula
  • Venturi Masks
  • Non-rebreather Masks
  • Bag Valve Masks
  • CPAP Masks
  • Others 

Breakup by Application:

• Chronic Obstructive Pulmonary Disease
• Asthma
• Obstructive Sleep Apnea
• Respiratory Distress Syndrome
• Cystic Fibrosis
• Pneumonia
• Others

Breakup by End Use:

• Home Healthcare
• Hospitals 

Breakup by Region:

• North America (USA, Canada)
• Europe (Germany, France, UK, Italy, Spain, Russia, others)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, others)
• Middle East/Africa
• Latin America (Brazil, Mexico, others)

Key Highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

About US:

IMARC Group is a leading market research firm that provides management strategy and market research worldwide. We work with clients in every sector and geography to identify their most valuable opportunities, address their most important challenges and transform their businesses.

The IMARC Group's information offerings include key market trends, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high technology sectors. Market forecasts and industry analysis in biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and innovative processing methods are among the company's top areas of expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163